Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 4:05 PM View:  | Morabito Christopher Chief Medical Officer | Astria Therapeutics, Inc. (ATXS) | 01-Apr-24 | Option Exercise | 10,000 | $3.87 | $38,700.00 | 100% 0 to 10.0K | |
| 03-Apr-24 4:05 PM View: | Morabito Christopher Chief Medical Officer | Astria Therapeutics, Inc. (ATXS) | 01-Apr-24 | Planned Option Sale | 10,000 | $13.59 | $135,939.00 | (100%) 10.0K to 0 | |
| 05-Feb-24 5:02 PM View: | Perceptive Advisors LLC Director | Astria Therapeutics, Inc. (ATXS) | 01-Feb-24 | Purchase | 2,481,350 | $12.09 | $29,999,500.00 | 62% 4.0M to 6.49M | |
| 30-Jan-24 5:03 PM View: | Morabito Christopher Chief Medical Officer | Astria Therapeutics, Inc. (ATXS) | 29-Jan-24 | Option Exercise | 9,200 | $3.87 | $35,604.00 | 100% 0 to 9.2K | |
| 30-Jan-24 5:03 PM View: | Morabito Christopher Chief Medical Officer | Astria Therapeutics, Inc. (ATXS) | 29-Jan-24 | Planned Option Sale | 9,200 | $11.15 | $102,552.00 | (100%) 9.2K to 0 | |
| 30-Jan-24 5:03 PM View: | Morabito Christopher Chief Medical Officer | Astria Therapeutics, Inc. (ATXS) | 26-Jan-24 | Planned Option Sale | 800 | $11.02 | $8,812.00 | (100%) 0.8K to 0 | |
| 30-Jan-24 5:03 PM View: | Morabito Christopher Chief Medical Officer | Astria Therapeutics, Inc. (ATXS) | 26-Jan-24 | Option Exercise | 800 | $3.87 | $3,096.00 | 100% 0 to 0.8K | |
| 22-Dec-23 2:51 PM View: | Perceptive Advisors LLC Director | Astria Therapeutics, Inc. (ATXS) | 21-Dec-23 | Private Purchase | 740,000 | $6.20 | $4,588,000.00 | 23% 3.26M to 4.0M | |
| 18-Oct-23 4:11 PM View: | Perceptive Advisors LLC Director | Astria Therapeutics, Inc. (ATXS) | 16-Oct-23 | Private Purchase | 1,074,610 | $6.51 | $7,000,000.00 | 49% 2.19M to 3.26M | |
| 21-Dec-22 4:52 PM View: | Perceptive Advisors LLC Director | Astria Therapeutics, Inc. (ATXS) | 19-Dec-22 | Purchase | 908,265 | $11.01 | $10,000,000.00 | 71% 1.28M to 2.19M | |
| 10-Feb-22 10:00 PM View: | Komjathy Andrew Chief Commercial Officer | Astria Therapeutics, Inc. (ATXS) | 28-Dec-21 | Gift | 90 | -- | -- | (47%) 0.19K to 100 | |
| 23-Nov-21 4:12 PM View: | Komjathy Andrew Chief Commercial Officer | Astria Therapeutics, Inc. (ATXS) | 19-Nov-21 | Private Purchase | 100 | $6.70 | $669.50 | 100% 0 to 100 | |
| 22-Sep-21 10:00 PM View: | Violin Jonathan Director | Astria Therapeutics, Inc. (ATXS) | 20-Sep-21 | Acquisition (other) | 263,321 | -- | -- | 100% 263.32K to 526.64K | |
| 22-Sep-21 10:00 PM View: | Violin Jonathan Director | Astria Therapeutics, Inc. (ATXS) | 20-Sep-21 | Disposition (other) | 263,321 | -- | -- | (50%) 526.64K to 263.32K | |
| 30-Jun-15 6:45 PM View: | Laufer Ron Director 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion Duplicate | 1,409,210 | -- | -- | 100% 0 to 1.41M | |
| 30-Jun-15 6:46 PM View: | Modi Rick Chief Business Officer | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion | 4,094 | -- | -- | 100% 0 to 4.09K | |
| 30-Jun-15 6:47 PM View: | Donovan Joanne M. Chief Medical Officer | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion | 409 | -- | -- | 100% 0 to 0.41K | |
| 30-Jun-15 6:48 PM View: | Jirousek Michael Chief Scientific Officer | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion | 67,067 | -- | -- | 37% 179.03K to 246.09K | |
| 30-Jun-15 6:46 PM View: | Svlsf V, LLC 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Purchase | 391,090 | $12.00 | $4,693,080.00 | 16% 2.47M to 2.86M | |
| 30-Jun-15 6:47 PM View: | George Jean Director | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Purchase | 258,776 | $12.00 | $3,105,310.00 | 16% 1.63M to 1.89M | |
| 30-Jun-15 6:45 PM View: | Medimmune Ventures, Inc. 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion | 1,409,210 | -- | -- | 100% 0 to 1.41M | |
| 30-Jun-15 6:46 PM View: | Svlsf V, LLC 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion | 2,466,580 | -- | -- | 100% 0 to 2.47M | |
| 30-Jun-15 6:47 PM View: | Galakatos Nicholas Director 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion Duplicate | 2,375,790 | -- | -- | 100% 0 to 2.38M | |
| 30-Jun-15 6:45 PM View: | Laufer Ron Director 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Purchase Duplicate | 223,439 | $12.00 | $2,681,270.00 | 16% 1.41M to 1.63M | |
| 30-Jun-15 6:47 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Purchase | 376,695 | $12.00 | $4,520,340.00 | 16% 2.38M to 2.75M | |
| 30-Jun-15 6:45 PM View: | Milne Jill C. President and CEO Director | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion | 74,846 | -- | -- | 42% 179.03K to 253.87K | |
| 30-Jun-15 6:47 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion | 2,375,790 | -- | -- | 100% 0 to 2.38M | |
| 30-Jun-15 6:47 PM View: | George Jean Director | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Conversion | 1,632,080 | -- | -- | 100% 0 to 1.63M | |
| 30-Jun-15 6:45 PM View: | Medimmune Ventures, Inc. 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Purchase | 223,439 | $12.00 | $2,681,270.00 | 16% 1.41M to 1.63M | |
| 30-Jun-15 6:47 PM View: | Galakatos Nicholas Director 10% Owner | Astria Therapeutics, Inc. (ATXS) | 30-Jun-15 | Purchase Duplicate | 376,695 | $12.00 | $4,520,340.00 | 16% 2.38M to 2.75M |
